- Home
- RVSB vs ARMP Comparison
RVSB vs ARMP Comparison
Compare RVSB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSB
- ARMP
- Stock Information
- Founded
- RVSB 1923
- ARMP N/A
- Country
- RVSB United States
- ARMP United States
- Employees
- RVSB N/A
- ARMP N/A
- Industry
- RVSB Savings Institutions
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVSB Finance
- ARMP Health Care
- Exchange
- RVSB Nasdaq
- ARMP Nasdaq
- Market Cap
- RVSB 107.6M
- ARMP 104.3M
- IPO Year
- RVSB 1993
- ARMP N/A
- Fundamental
- Price
- RVSB $5.28
- ARMP $3.14
- Analyst Decision
- RVSB Buy
- ARMP Strong Buy
- Analyst Count
- RVSB 1
- ARMP 1
- Target Price
- RVSB $7.00
- ARMP $9.00
- AVG Volume (30 Days)
- RVSB 78.3K
- ARMP 7.8K
- Earning Date
- RVSB 10-23-2025
- ARMP 11-12-2025
- Dividend Yield
- RVSB 1.52%
- ARMP N/A
- EPS Growth
- RVSB 163.90
- ARMP N/A
- EPS
- RVSB 0.24
- ARMP N/A
- Revenue
- RVSB $51,318,000.00
- ARMP $6,868,000.00
- Revenue This Year
- RVSB $11.67
- ARMP $8.43
- Revenue Next Year
- RVSB $12.55
- ARMP N/A
- P/E Ratio
- RVSB $21.96
- ARMP N/A
- Revenue Growth
- RVSB 9.48
- ARMP 84.67
- 52 Week Low
- RVSB $4.45
- ARMP $0.90
- 52 Week High
- RVSB $6.59
- ARMP $3.23
- Technical
- Relative Strength Index (RSI)
- RVSB 56.96
- ARMP 61.13
- Support Level
- RVSB $5.17
- ARMP $3.08
- Resistance Level
- RVSB $5.44
- ARMP $3.07
- Average True Range (ATR)
- RVSB 0.12
- ARMP 0.08
- MACD
- RVSB 0.01
- ARMP 0.00
- Stochastic Oscillator
- RVSB 60.53
- ARMP 68.75
About RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.